
Addressing COVID-19 helped boost Pfizer's sales to record levels. Now with the pandemic increasingly in the rear-view mirror, CEO Albert Bourla says cancer is the company's next big target—and thinks "Chinese science" can be the source of new innovations to "help the world's patients."
Pfizer needs new goals as it shifts to a "period of peace," after a "period of war" during the COVID pandemic, Bourla told Fortune editor-in-chief Alyson Shontell at the Fortune Global 500 Summit in Guangzhou on Thursday.